1. CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy
   Valerio Nardone et al, 2021, International Journal of Molecular Sciences CrossRef
2. A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma
   Jian Zhang et al, 2020, BMC Cancer CrossRef
3. Inhibitor of Multi-cyclin-dependent Kinases (AT7519) Reduced Survival of U937 Leukemic Cells and Enhanced Anti-leukemic Effect of Vincristine: A Highlight to CDK Inhibition Efficacy in Acute Leukemia
   Fateme Moradi Moraddahande et al, 2021, International Journal of Cancer Management CrossRef
4. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer
   María del Mar Noblejas-López et al, 2022, International Journal of Molecular Sciences CrossRef
5. Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells
   Eva-Maria Faulhaber et al, 2021, Genes CrossRef
6. Inhibition of cyclin-dependent kinases by AT7519 enhances nasopharyngeal carcinoma cell response to chemotherapy
   Xin Wei et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
7. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis
   Xiangxin Zhang et al, 2020, Oncology Research and Treatment CrossRef